Furiex Pharmaceuticals, Inc. (FURX) Reports First Quarter 2013 Financial Results
5/8/2013 7:48:57 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Announces First Quarter 2013 Earnings Release and Conference Call
4/10/2013 6:16:37 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) to Receive Milestone Payment for Priligy® Launch in France
4/4/2013 11:36:38 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Reports Fourth Quarter and Full Year 2012 Financial Results
3/7/2013 6:17:50 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) to Present at Cowen and Company 33rd Annual Healthcare Conference
2/26/2013 7:19:50 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call
1/30/2013 6:08:03 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Reports Third Quarter 2012 Financial Resultsf
11/2/2012 8:30:57 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Announces Third Quarter 2012 Earnings Release and Conference Call
10/2/2012 10:14:38 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements
7/31/2012 9:45:50 AM
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Resubmissions of Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone NDAs to the FDA
7/30/2012 9:58:19 AM
More...
|
|